ÌÇÐÄÆƽâ°æ

This statistic presents the distribution of Novo Nordisk's revenue in 2022, by geographic region. Novo Nordisk is a Danish pharmaceutical group operating internationally and is headquartered in Bagsværd, near Copenhagen. The company specializes in treatments for diabetes, as well as hemostasis, growth hormone, and hormonal treatments. Novo Nordisk was formed in 1989 from the merger of two Danish pharmaceutical companies: Novo Industri and Nordisk Gentofte. Established in France since 1961, Novo Nordisk maintains a production site in Chartres that produces insulin cartridges. The assembly and packaging of insulin injection pens also take place there. In 2022, the revenue generated in North America accounted for more than half of Novo Nordisk's total revenue.